Patents by Inventor Eric R. First

Eric R. First has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF
    Publication number: 20230180810
    Abstract: Disclosed herein are embodiments of stress eating dosage forms and foods, stressed gut dosage forms and foods, and methods of preparation and use thereof. Stress eating dosage forms and foods can include at least one sensory disrupter including an aromatic oil and at least one functional food, including one or more of a fruit, vegetable, plant-based oil, nut, nut oil, seed, seed oil, syrup, sugar, butter, grain, pseudo grain, mushroom, herb, spice, acid, plant portions or matter thereof, extracts thereof, or combinations thereof.
    Type: Application
    Filed: December 12, 2022
    Publication date: June 15, 2023
    Inventor: Eric R. First
  • DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF
    Publication number: 20220192993
    Abstract: Disclosed are dosage forms and kits that support the human body during a stress response. The dosages forms can include at least one sensory disrupter, at least one stress-buster and at least one calming reliever. In embodiments, the dosage form can include at least one nervous system component, at least one immune system component, and at least one endocrine system component. Also disclosed are kits containing the dosage forms and methods of preparation and use of such dosage forms.
    Type: Application
    Filed: April 3, 2020
    Publication date: June 23, 2022
    Inventor: Eric R. First
  • Method and composition to improve absorption of therapeutic agents
    Patent number: 11135188
    Abstract: A tablet with an enhanced dissolution profile for a medicinally active ingredient such as aspirin and methods for making the tablet. The tablet comprises a blend of crystals of the medicinally active ingredient and a dissolution aid such as sodium or calcium carbonate or bicarbonate that coats the crystals upon co-milling. The blend is then compressed to form tablets that have an enhanced dissolution profile for the medicinally active ingredient.
    Type: Grant
    Filed: May 11, 2009
    Date of Patent: October 5, 2021
    Assignee: Bayer HealthCare LLC
    Inventors: Eric R. First, Ashish B. Patel, Guido Schmitz, Stephanie Petaway-Hickson, Hung-Huar Tong
  • Botulinum toxin therapy for skin disorders
    Patent number: 10245305
    Abstract: Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.
    Type: Grant
    Filed: April 17, 2015
    Date of Patent: April 2, 2019
    Assignee: Allergan, Inc.
    Inventor: Eric R. First
  • Botulinum toxin therapy for skin disorders
    Patent number: 10076557
    Abstract: Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.
    Type: Grant
    Filed: September 23, 2014
    Date of Patent: September 18, 2018
    Assignee: Allergan, Inc.
    Inventor: Eric R. First
  • BOTULINUM TOXIN THERAPY FOR SKIN DISORDERS
    Publication number: 20150216953
    Abstract: Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.
    Type: Application
    Filed: April 17, 2015
    Publication date: August 6, 2015
    Inventor: Eric R. First
  • Cosmetic neurotoxin compositions and methods
    Patent number: 9056059
    Abstract: Cosmetic compositions include a Clostridial neurotoxin component and a microsphere component. In certain compositions, the composition includes a botulinum toxin and a plurality of swellable microspheres. The compositions are administered to individuals, by injection and the like, to treat a cosmetic defect of deficiency.
    Type: Grant
    Filed: December 30, 2013
    Date of Patent: June 16, 2015
    Assignee: Allergan, Inc.
    Inventor: Eric R. First
  • BOTULINUM TOXIN THERAPY FOR SKIN DISORDERS
    Publication number: 20150010533
    Abstract: Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.
    Type: Application
    Filed: September 23, 2014
    Publication date: January 8, 2015
    Inventor: Eric R. First
  • Pressure sore treatment
    Patent number: 8865177
    Abstract: Methods for treating a pressure sore or for preventing development of a pressure sore by local administration of a Clostridial toxin, such as a botulinum neurotoxin, to a pressure sore or to a pressure point, or to the vicinity thereof.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: October 21, 2014
    Assignee: Allergan, Inc.
    Inventor: Eric R. First
  • COSMETIC NEUROTOXIN COMPOSITIONS AND METHODS
    Publication number: 20140112967
    Abstract: Cosmetic compositions include a Clostridial neurotoxin component and a microsphere component. In certain compositions, the composition includes a botulinum toxin and a plurality of swellable microspheres. The compositions are administered to individuals, by injection and the like, to treat a cosmetic defect of deficiency.
    Type: Application
    Filed: December 30, 2013
    Publication date: April 24, 2014
    Inventor: Eric R. First
  • Cosmetic neurotoxin compositions and methods
    Patent number: 8647639
    Abstract: Cosmetic compositions include a Clostridial neurotoxin component and a microsphere component. In certain compositions, the composition includes a botulinum toxin and a plurality of swellable microspheres. The compositions are administered to individuals, by injection and the like, to treat a cosmetic defect of deficiency.
    Type: Grant
    Filed: January 27, 2010
    Date of Patent: February 11, 2014
    Assignee: Allergan, Inc.
    Inventor: Eric R. First
  • Method for treating a keloid with a botulinum toxin
    Patent number: 8530410
    Abstract: Methods for treating melanin related afflictions by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a melanin related affliction.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: September 10, 2013
    Assignee: Allergan, Inc.
    Inventor: Eric R. First
  • Method and composition to improve absorption of therapeutic agents
    Publication number: 20130122098
    Abstract: A tablet with an enhanced dissolution profile for a medicinally active ingredient such as aspirin and methods for making the tablet. The tablet comprises a blend of crystals of the medicinally active ingredient and a dissolution aid such as sodium or calcium carbonate or bicarbonate that coats the crystals upon co-milling. The blend is then compressed to form tablets that have an enhanced dissolution profile for the medicinally active ingredient.
    Type: Application
    Filed: November 14, 2011
    Publication date: May 16, 2013
    Applicant: Bayer HealthCare LLC
    Inventors: Eric R. First, Ashish B. Patel, Guido Schmitz, Stephanie Petaway-Hickson, Hung-Huar Tong
  • Calcium supplement
    Publication number: 20120244218
    Abstract: An oral dosage form for administration to an animal comprising a biologically utilizable form of calcium and a extended release system that maintains the calcium level in the animal's bloodstream at a substantially beneficial level for a defined period of time.
    Type: Application
    Filed: March 25, 2011
    Publication date: September 27, 2012
    Inventors: Shane E. Durkee, Pradnya Beke, Eric R. First, Ashish B. Patel
  • Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
    Publication number: 20110300216
    Abstract: A tablet comprising: (a) an active ingredient; and (b) at least one member of an effervescent couple, wherein said tablet dissolves in water in not more than three minutes and in the mouth in not more than thirty seconds, and wherein said tablet is capable of acting as an effervescent tablet, a rapid-dissolve tablet or a rapidly disintegrating swallow tablet.
    Type: Application
    Filed: June 3, 2010
    Publication date: December 8, 2011
    Inventors: Eric R. First, Ashish Bipin Patel, Hung-Huar Tong
  • Botulinum toxin therapy for skin disorders
    Patent number: 8048423
    Abstract: Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.
    Type: Grant
    Filed: December 9, 2003
    Date of Patent: November 1, 2011
    Assignee: Allergan, Inc.
    Inventor: Eric R. First
  • Method and composition to improve absorption of therapeutic agents
    Publication number: 20100286100
    Abstract: A tablet with an enhanced dissolution profile for a medicinally active ingredient such as aspirin and methods for making the tablet. The tablet comprises a blend of crystals of the medicinally active ingredient and a dissolution aid such as sodium or calcium carbonate or bicarbonate that coats the crystals upon co-milling. The blend is then compressed to form tablets that have an enhanced dissolution profile for the medicinally active ingredient.
    Type: Application
    Filed: May 11, 2009
    Publication date: November 11, 2010
    Inventors: Eric R. First, Ashish B. Patel, Guido Schmitz, Stephanie Petaway-Hickson, Hung-Huar Tong
  • Personal warming apparatus for waist
    Patent number: D627078
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: November 9, 2010
    Assignee: Kobayashi Pharmaceutical Co., Ltd.
    Inventors: Atsushi Matsuo, James McCay, Ashish B. Patel, Eric R. First
  • Personal warming apparatus for hand
    Patent number: D627896
    Type: Grant
    Filed: March 15, 2010
    Date of Patent: November 23, 2010
    Assignee: Kobayashi Pharmaceutical Co., Ltd.
    Inventors: Atsushi Matsuo, Jonathan Lee, James McCay, Ashish B. Patel, Eric R. First
  • Personal warming apparatus for knee
    Patent number: D630759
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: January 11, 2011
    Assignee: Kobayashi Pharmaceutical Co., Ltd.
    Inventors: Atsushi Matsuo, James McCay, Karen E. Kleiman, Ashish B. Patel, Eric R. First